REGENOCELL THERAPEUTICS, INC. Operating Cash Flow
REGENOCELL THERAPEUTICS, INC. reported Operating Cash Flow of -$317.46 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-05-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-05-25
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was -$468.34K.
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was -$326.42K.
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2010-12-31 was -$119.04K.
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2010-09-30 was -$217.67K.
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2011 was -$317.46K.
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2010 was -$177.41K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2011-12-31 | -$468.34K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | -$794.76K derived: sum of 2 quarters · filed 2012-05-25 | -$317.46K 10-K · filed 2012-05-25 | |
| 2011-09-30 | -$326.42K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $150.88K 10-Q · filed 2011-11-21 | ||
| 2011-06-30 | $477.31K 10-Q/A · filed 2011-09-01 | |||
| 2010-12-31 | -$119.04K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | -$336.72K derived: sum of 2 quarters · filed 2012-05-25 | -$177.41K 10-K · filed 2012-05-25 | |
| 2010-09-30 | -$217.67K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | -$58.36K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $159.31K 10-Q/A · filed 2011-09-01 |